Evidence map›Paper›PMID 40889615›Full record

ArticleOsteoarthritis and cartilage2026

Cross-platform transcriptomic data integration identifies an overactive neuro-immune signature in human osteoarthritis synovium.

Michael D Newton, Hannah Swahn, Dana E Orange, Joseph B Lesnak, Theodore J Price, Anne-Marie Malfait, Rachel E Miller, Martin K Lotz, RE-JOIN Consortium Investigators, Tristan Maerz

Abstract read
In one paragraph

Article in Osteoarthritis and cartilage, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Synovial fibroblasts modulate endothelial activation in an acute injury-on-a-chip model.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Article
  7. Review
  8. Osteoarthritis as a systemic disease.Nature reviews. Rheumatology · 2026
    Review
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Michael D NewtonDepartment of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USA. Electronic address: nemichae@umich.edu.
Hannah SwahnDepartment of Molecular Medicine, Scripps Research, La Jolla, California, USA. Electronic address: hswahn@scripps.edu.
Dana E OrangeLaboratory of Molecular Neuro-Oncology, Rockefeller University, New York, NY, USA; Department of Medicine, Division of Rheumatology, Hospital for Special Surgery, New York, NY, USA. Electronic address: dorange@rockefeller.edu.
Joseph B LesnakDepartment of Neuroscience and Center for Advanced Pain Studies, University of Texas at Dallas, Richardson, TX, USA. Electronic address: joseph.lesnak@utdallas.edu.
Theodore J PriceDepartment of Neuroscience and Center for Advanced Pain Studies, University of Texas at Dallas, Richardson, TX, USA. Electronic address: Theodore.Price@utdallas.edu.
Anne-Marie MalfaitDivision of Rheumatology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA. Electronic address: anne-marie_malfait@rush.edu.
Rachel E MillerDivision of Rheumatology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA. Electronic address: rachel_miller@rush.edu.
Martin K LotzDepartment of Molecular Medicine, Scripps Research, La Jolla, California, USA. Electronic address: mlotz@scripps.edu.
RE-JOIN Consortium Investigators
Tristan MaerzDepartment of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USA; Institute for Biomechanics, Department of Health Sciences and Technology, ETH Zürich, Zürich, Switzerland; Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI, USA; Department of Biomedical Engineering, Division of Rheumatology, University of Michigan, Ann Arbor, MI, USA. Electronic address: maerzt@ethz.ch.

Funding

Precision Mapping of Knee Pain in Osteoarthritis: Understanding differences between pain with activity and restUC2AR082186 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI LOTZ, MARTIN K, MALFAIT, ANNE-MARIE · 2022 to 2025
$11.9M
NIAMS NIH HHS UC2 AR082186
6 · The paper itself

Abstract

objectiveChronic synovitis is associated with osteoarthritis (OA) pain, but the molecular underpinnings remain unclear. Our objective was to characterize the transcriptional phenotype of OA synovium with a focus on signaling relevant to pain.

designEight publicly-available microarray and RNA-sequencing GEO datasets from human non-OA and OA subjects underwent quality control and re-analysis for differentially-expressed genes (DEGs). Cross-platform statistical integration was performed via a weighted Z-test to combine detection power across datasets. Gene set enrichment, cell type enrichment, and regulon analyses were performed. Human single-cell RNA sequencing data was used to map gene expression to cell types. Ligand-receptor interactions were predicted via multi-omic data from human dorsal root ganglia (DRG).

resultsFollowing statistical integration of individual studies (N=153 total subjects, N=139 after quality control), gene set enrichment analysis identified 276 differentially-activated pathway terms in OA synovium, including strong enrichment for pathways related to innate and adaptive immunity (notably MHC Class II) and fibrotic remodeling-relevant extracellular matrix organization. VEGF signaling and angiogenesis-related terms were downregulated. Enriched pain and neuronal pathways primarily related to neuro-immune interactions, including neuroinflammation, and were associated with macrophages, B and T lymphocytes, and synovial fibroblasts. A gene regulatory network comprised of STAT1, FLI1, and VDR putatively governed the expression of 27 genes driving neuro-immune signaling. An unbiased synovium-DRG interactome predicted 76 potential interactions between synovial cells and DRG nociceptors, involving 68 neuronal receptors interacting with 32 ligands overexpressed in OA synovium.

conclusionsEnd-stage OA synovium is markedly enriched for neuroinflammatory and neuro-immune signaling, putatively governed by STAT1, FLI1, and VDR.

Indexed as

OsteoarthritisOsteoarthritis, KneeSynovial MembraneTranscriptomeGanglia, SpinalGene Expression ProfilingHumans

Identifiers

PMID40889615
PMCPMC13112359

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.